Ascletis Selects a Next-Generation Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development20/01/2026PR Newswire
Zadarma เปิดตัว AI Voice Agent ผู้ช่วยอัจฉริยะสำหรับภาคธุรกิจ รองรับ 8 ภาษา พร้อมสื่อสารกับลูกค้าตลอด 24 ชั่วโมง20/01/2026PR Newswire
GIBO Advances Toward Integrated Autonomous Mobility Systems, Building a Unified AI Stack Across Air and Ground Platforms20/01/2026PR Newswire
Telix Achieves FY 2025 Guidance with US$804M (A$1.2B) Revenue, Accelerates Growth with Gozellix Launch20/01/2026PR Newswire
Klook’s study of 374,000 reviews finds that lesser-known cities create deeper emotional connection with travelers20/01/2026PR Newswire
LSBF Singapore Campus and Deloitte Elevate Diploma Education in Singapore with Industry-Driven Learning20/01/2026PR Newswire
G42 Introduces Digital Embassies and Greenshield to Make AI Sovereignty Portable20/01/2026PR Newswire
Infinitus Recognised as a Top Employer in China for 2026 for the Sixth Consecutive Year20/01/2026PR Newswire
Alteogen Announces Exclusive License Agreement with Tesaro, a Subsidiary of GSK, for the Development of a Subcutaneous Formulation of Dostarlimab Enabled by Hybrozyme™ Technology20/01/2026PR Newswire
